Regularly discharging baroreceptors in a rat in vitro aortic arch preparation were exposed to increasing concentrations of one of four vasoactive peptides: angiotensin II, arginine vasopressin, atrial natriuretic factor, or substance P. Slow ramps of pressure evoked discharge responses in single-fiber baroreceptors. Instantaneous discharge frequency was measured simultaneously with aortic diameter and pressure. During constriction induced by angiotensin II or arginine vasopressin, baroreceptor diameter threshold (Dth) decreased and pressure threshold (Pth) tended to increase; these effects were reduced or eliminated by nitroprusside. Atrial natriuretic factor and substance P by themselves were without effect on vessel diameter or on baroreceptor discharge. In preparations preconstricted with a moderate concentration of phenylephrine (10-8 M), atrial natriuretic factor reduced the phenylephrine-induced constriction and increased Dth and decreased Pth. Substance P, even at high concentrations, was less effective than atrial natriuretic factor in reducing phenylephrine constriction and in altering baroreceptor discharge. Baroreceptor gain was unaffected by any of these peptides. Thus, changes in smooth muscle tone altered mechanotransduction by shifts in 1) the vessel pressure-diameter relation and 2) baroreceptor threshold requirements (Pth and Dth). Changes in the baroreceptor mechanical threshold (Dth) reduced the effects on Pth expected from changes in vessel wall mechanics. Pth reflects the net effects of vessel wall and Dth changes. Pth generally increased during constrictions and decreased during dilations. The changes in Dth and their selectivity (no changes in gain) during vasoactive peptide action closely resemble rapid resetting of baroreceptors. We propose that vascular smooth muscle lies in a parallel arrangement with aortic baroreceptors and that a common compensatory mechanism regulates Dth during sustained changes in vessel diameter. Activation of smooth muscle and reductions in transmural pressure would reduce loading of baroreceptors, and the proposed compensatory mechanism would tend to keep discharge constant by decreasing Dth. Our experiments, however, cannot distinguish between hypotheses for local micromechanical changes in coupling or for changes modulating excitability within the baroreceptor neuron itself as the basis for Dth adjustments. (Circulation Research 1990;66:804-813 
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Regularly discharging baroreceptors in a rat in vitro aortic arch preparation were exposed to increasing concentrations of one of four vasoactive peptides: angiotensin II, arginine vasopressin, atrial natriuretic factor, or substance P. Slow ramps of pressure evoked discharge responses in single-fiber baroreceptors. Instantaneous discharge frequency was measured simultaneously with aortic diameter and pressure. During constriction induced by angiotensin II or arginine vasopressin, baroreceptor diameter threshold (Dth) decreased and pressure threshold (Pth) tended to increase; these effects were reduced or eliminated by nitroprusside. Atrial natriuretic factor and substance P by themselves were without effect on vessel diameter or on baroreceptor discharge. In preparations preconstricted with a moderate concentration of phenylephrine (10-8 M) , atrial natriuretic factor reduced the phenylephrine-induced constriction and increased Dth and decreased Pth. Substance P, even at high concentrations, was less effective than atrial natriuretic factor in reducing phenylephrine constriction and in altering baroreceptor discharge. Baroreceptor gain was unaffected by any of these peptides. Thus, changes in smooth muscle tone altered mechanotransduction by shifts in 1) the vessel pressure-diameter relation and 2) baroreceptor threshold requirements (Pth and Dth). Changes in the baroreceptor mechanical threshold (Dth) reduced the effects on Pth expected from changes in vessel wall mechanics. Pth reflects the net effects of vessel wall and Dth changes. Pth generally increased during constrictions and decreased during dilations. The changes in Dth and their selectivity (no changes in gain) during vasoactive peptide action closely resemble rapid resetting of baroreceptors. We propose that vascular smooth muscle lies in a parallel arrangement with aortic baroreceptors and that a common compensatory mechanism regulates Dth during sustained changes in vessel diameter. Activation of smooth muscle and reductions in transmural pressure would reduce loading of baroreceptors, and the proposed compensatory mechanism would tend to keep discharge constant by decreasing Dth. Our experiments, however, cannot distinguish between hypotheses for local micromechanical changes in coupling or for changes modulating excitability within the baroreceptor neuron itself as the basis for Dth adjustments. (Circulation Research 1990;66:804-813) P eptides have been implicated as neurotransmitters or modulators in the peripheral and central portions of the nervous system concerned with cardiovascular regulation.1-4 The evidence includes anatomic localization, accumulation/ depletion/release, responses to exogenous peptide, and competitive inhibition of some of these actions by synthetic analogues. Although the physiological function of many peptides is uncertain, there is a growing consensus that peptides serve as hormonal and neurotransmitter modulators in various tissues.
Recently, investigators have suggested that several different peptides may act to modify the discharge characteristics of cardiovascular mechanoreceptors and, thereby, influence baroreflex control systems. [5] [6] [7] Intravenous infusions of arginine vasopressin (AVP) enhanced discharge during pressure elevation in single aortic baroreceptors of rabbits and in left ventricular mechanoreceptors of cats.8 Sensitization of afferents could contribute to baroreflex augmentation.9'10 In the rat, infusion of atrial natriuretic factor (ANF) evoked smaller than expected reflex changes in renal sympathetic nerve activity, and the authors suggested that ANF sensitized vagal afferents.5,1'
A third peptide, substance P (subP), has been considered a potential candidate for local modula-tion of baroreceptors. Immunoreactive labeling indicates substantial concentrations of subP in the aortic arch and carotid sinus regions.12-14 Since other sensory nerves are known to release subP at their peripheral endings,12 some have speculated that subP might have some local regulatory actions on baroreceptors. 13 It is unclear whether subP is released by peripheral baroreceptor endings12 or under which conditions release might occur.
Little is known about the precise mechanism of action of infusions of AVP or ANF on baroreceptor or baroreflex responses. Many peptides are vasoactive. AVP is a potent vasoconstrictor. ANF and subP are vasodilatory. Contraction or relaxation of vascular smooth muscle near arterial baroreceptors is known to alter discharge of arterial baroreceptors.15 '16 In this report, we examine the response of aortic baroreceptors to the peptides angiotensin II (Ang II), AVP, ANF, and subP using an in vitro preparation in which conditioning and stimulating pressures can be rigorously controlled. We monitored discharge, pressure, and aortic diameter simultaneously to assess effects on baroreceptor pressure and mechanical responsiveness.
Materials and Methods
Single-fiber baroreceptors were studied in an in vitro preparation of the aortic arch using male Sprague-Dawley rats (Harlan Sprague-Dawley, Indianapolis, Indiana). Methods for testing baroreceptors have been described in detail previously. 17 Briefly, under sodium pentobarbital anesthesia (30-50 mg/kg), the aortic arch-and aortic nerve were exposed. Metal cannulas were placed in the innominate artery and the descending aorta. Ligatures were placed on the ascending aorta and the left common carotid and left subclavian arteries. The aortic arch and nerve were removed and transferred to a temperature-regulated perfusion bath in which the vessel was fixed to approximate its in situ length and shape. The aortic lumen was perfused with KrebsHenseleit solution equilibrated with 95% 02-5% CO2 gas mixture, and the preparation was covered with warm mineral oil. 17 To Experiments were recorded on analog FM magnetic tape and later played back for digitization by a microcomputer (PDP 11/23). Diameter and pressure were sampled each 100 msec. Spike sorting21 was used in one animal to separate a pair of baroreceptors recorded simultaneously. Discharge rate was measured by the computer as spike-triggered interrupts and expressed as the instantaneous frequency (reciprocal of the interspike interval). Pressuredischarge and diameter-discharge relations were constructed for each ramp response. Typically, these relations have a distinct minimum pressure and diameter at which discharge begins and a suprathreshold region in which discharge increases linearly in response to increases in pressure. 17 For a given experiment to be accepted for analysis, test solutions at a minimum of four log concentrations (10,000-fold) had to be successfully completed. Across all protocols, dose-response curves in a total of 27 single-fiber baroreceptors from 26 animals met these criteria. In one animal, a pair of baroreceptors were recorded simultaneously and separated by spike sorting. 21 Only one drug protocol was tested on each baroreceptor. Effective test solutions generally produced dose-dependent parallel shifts of the baroreceptor pressure-discharge or baroreceptor diameterdischarge curves along the x axis, that is, changes in threshold values. Dose-response curves were constructed for each test solution by averaging the magnitude of these curve shifts from the several ramp tests at each concentration and plotting these values against the log of the peptide concentration. Since we had multiple measurements of baroreceptor properties at each concentration within each experiment, difference testing was carried out at two levels: effects within experiments and summary normalized results averaged across experiments. Relations for individual baroreceptors were tested by analysis of variance or multiple linear regression analysis. 24 The pattern of these individual within-experiment results are noted in each section of "Results." To display average effects and to assess the general response across all baroreceptors tested with the same protocol, the data in individual experiments were normalized within experiments as the mean value of the multiple measurements relative to control. Thus, each value of the test parameter (Pth, Dth, or diameter at a fixed pressure) was divided by the mean of measurements during control (drug-free) conditions. For (Figure 1 , middle panel). There was no general change in the slope (gain) of the diameter-discharge curves during these shifts. Dth, the minimum diameter required for baroreceptor excitation, decreased in a dosedependent manner (inset to middle panel of Figure  1 ). Second, as Ang II was increased, the pressuredischarge curves shifted in a parallel manner to higher pressures ( Figure 1, bottom panel) . Pth requirements were substantially higher during Ang II constriction (inset to bottom panel of Figure 1 ), but the suprathreshold pressure gain (slope) was unchanged. Addition of NP greatly reduced or eliminated the aortic constriction and the effects on baroreceptor discharge curves (Dth and Pth), even in the continuing presence of the maximal Ang II concentration (NP points in insets of Figure 1 (Figure 2 ). In separate experiments (n=4 from three rats) in which NP was present throughout, concentrations of Ang II up to 10-6 M did not affect diameter, Pth, or Dth (p>0.54).
Vasopressin
The effects of AVP on aortic baroreceptors were more variable than Ang II, and this appears to be related to the more variable response of aortic smooth muscle to AVP. AVP (> 10-10 M) constricted the aortic arch ( Figure 3 , top panel). The AVP constrictions, however, tended to relax somewhat (inset to top panel of Figure 3 ) after several minutes of perfusion at high concentrations (>10o-8 M). With increasing AVP, baroreceptor diameter-discharge curves shifted to lower diameter ranges in a parallel manner (Figure 3, middle panel) . The changes in Dth followed the general response pattern for aortic diameter constriction as found with Ang II. Dth decreased substantially with the decreases in diameter from control to 10-8 M AVP, but at variable concentrations greater than 10-8 M, aortic diameter and Dth increased with further increases in AVP (inset to middle panel of Figure 3 ). The shifts in the pressure-discharge curves of individual baroreceptors ( Figure 3 , bottom panel) were parallel, but the magnitude of the shifts was generally small. Addition of NP for this baroreceptor eliminated most of the change in diameter and Dth.
In individual experiments with complete doseresponse curves (n=5 from five rats), most (four of five) baroreceptors had small increases in Pth with AVP up to a +7 mm Hg shift (not shown), a direction of change similar to Ang II baroreceptor responses. One baroreceptor had small, but significant (p<0.05), decreases in Pth (Figure 3 ). On average, compared with drug-free controls (n=5 from five rats), AVP maximally reduced aortic diameter and Dth to 84.2±1.2% and 90.7±1.2%, respectively, but Pth increased insignificantly to only 103.4+1.3% during AVP (Figure 2) . The presentation and group statistics of the AVP data ( Figure 2) Figure 1 , but addition of AVP was without further effect.
Atrial Natriuretic Factor ANF alone, even at very high concentrations (10-M), was without effect on diameter, Dth, Pth, or the slopes of the baroreceptor discharge-response curves (p>0.5). Low to moderate concentrations of the a1-agonist PE constricted the aortic arch and reduced baroreceptor discharge at any given pressure ( Figure  4, bottom panel) . Addition of ANF to perfusate containing PE dilated the aortic arch from the PEalone value (Figure 4, top panel) . PE constriction decreased Dth substantially (insert of middle panel of Figure 4 ), and addition of ANF to the PE perfusate increased Dth values. Pth was substantially increased during PE alone, and ANF reduced the PE effect ( Figure 4 , bottom panel). High concentrations of ANF (10`M) returned diameter, Dth, and Pth to values close to those of the initial drug-free state. This pattern was found in all baroreceptors tested. On average, compared with drug-free controls (n=3 from three rats), PE constriction reduced aortic diameter and Dth to 81.6+1.9% and 83.7±1.4%, respectively, and increased Pth (107.6+1.2%; Figure  5 ). On average, high concentrations of ANF restored diameter, Dth, and Pth values to near their drug-free control values ( Figure 5 ; p>0.5).
Substance P SubP alone failed to affect diameter, Dth, Pth, or the slopes of the baroreceptor discharge-response curve (p>0.5). In one of five cases, subP, like ANF, relaxed PE-constricted aortas ( Figure 6, top panel) . In this baroreceptor, subP-induced relaxation was accompanied by a return of Dth and Pth to near drug-free values despite the presence of PE ( Figure  6 , middle and bottom panels). Of the five baroreceptors in which dose-response curves were completed, high concentrations of subP failed to normalize the vessel wall and baroreceptor discharge curves in four cases. Thus, on average, compared with drug-free controls (n =5 from five rats), subP only partially dilated aortic diameter from 84.4+2.1% during PE to 90.2+3.9% during subP plus PE ( Figure 5 ). Across the five-unit averages, addition of subP failed to affect PE-induced changes in Dth or Pth ( Figure 5 , p>0.5). However, when subP produced aortic relaxation, the pattern of baroreceptor response was similar to that of ANF ( Figure 6 ). C PE 10 9 8 7 6 C PE 10 9 8 7 6 C PE 10 9 8 7 6 -log [Sub In studies of norepinephrine and Ang II, Munch et a116 described aortic baroreceptor discharge responses during vasoconstriction under two conditions: 1) when aortic diameter was held constant by adjusting the transmural pressure (isometric condi-tions) and 2) when pressure was held constant by a pressure regulator and diameter was free to constrict (isotonic conditions). Baroreceptor discharge decreased during isotonic vasoconstriction ( Figure 6 of Reference 16), similar to our own results and conditions. Discharge increased, however, during isometric vasoconstriction in which transmural pressure was increased to offset the tendency for vessel diameter to decrease (Figure 7 of Reference 16). Munch et al reasoned, as we have, that discharge decreased during isotonic responses due to baroreceptor unloading. In light of the results of our study, we would add that baroreceptor unloading (increased Pth) during isotonic vasoconstriction resulted from the quantitative predominance of the change in vessel wall mechanics (the shift in the pressure-diameter curve to lower pressures) over the opposing compensatory reduction in Dth. The increases in discharge during isometric contractions, they suggested, might result from changes in wall tension or contraction of smooth muscle coupled in series to the baroreceptor endings. Munch et al produced an isotonic diameterdischarge curve by gradually increasing Ang II concentration and measuring diameter and discharge at a single fixed pressure ( Figure 6D of Reference 16). This composite curve had a lower slope but higher discharge frequencies than the diameter-discharge curve evoked by changing pressure. Neither baroreceptor threshold nor the complete diameterdischarge relation was measured at each Ang II concentration in their studies. Our results suggest that the relative elevation in discharge rate during constriction at constant diameters (isometric) was due to the progressive decrease in baroreceptor setpoint, Dth. We observed no changes in sensitivity (slope) of the baroreceptor diameter-discharge curves between conditions of maximal vasoconstriction and complete relaxation (NP). Thus Pth, the composite of vessel wall and Dth effects, always changes in the direction of Dth.
Discussion

Possible Mechanisms for Dth Changes
The nature or identity of the mechanism or structures responsible for changes in Dth is difficult to determine. It is tempting to speculate that the same mechanism is responsible for the adjustments in Dth both during changes in smooth muscle tone and during prolonged conditioning pressure changes (rapid resetting). We propose that at least two key elements in the mechanotransduction cascade could conceivably be responsible for Dth regulation: 1) a coupling element arranged in series with the baroreceptor ending or 2) excitability of the baroreceptor neuron itself. The experimental observations suggest a relation between sustained diameter and Dth that would, in effect, provide a negative feedback tending to maintain baroreceptor discharge more constant.
In the mechanical coupling concept, a serial element is thought to link distortions of the vessel wall with distortions of the mechanosensitive baroreceptor endings.33 Viscous relaxation of this coupling element could give the time-dependent properties associated with rapid resetting and could unload baroreceptor endings at a microscopic level (i.e., undetectable by gross diameter measurements). To be consistent with our measurements of aortic diameter and baroreceptor activity, the major portion of the vessel wall (e.g., media and intimal layers remote from the baroreceptor endings) would have to function in parallel to the baroreceptor and the seriescoupling element, which are probably confined to the adventitia. 35 Local unloading of the baroreceptors would occur whenever diameter is increased for a prolonged time period of minutes to hours. Thus, vasodilation at constant pressure or increases in passive pressure distension (hypertensive rapid resetting) both lead to increases in diameter and Dth. The hypothesized serial coupling element would act micromechanically to reduce changes in baroreceptor distortion and, therefore, discharge output without affecting the gross vessel wall properties.
Alterations of membrane excitability within the baroreceptor are a second possible explanation of the changes in Dth.1836,37 Mechanical transmission of vessel distention to the baroreceptor ending could be unchanged during the challenge. Instead, the mechanotransduction process converting ending distortion to discharge could adapt to become less responsive. Precedence exists in vertebrate muscle spindle mechanoreceptors, in which direct measurements suggest that mechanical changes cannot account for adaptation.38
The present baroreceptor experiments cannot distinguish between hypotheses involving local micromechanical changes in coupling and changes modulating excitability within the baroreceptor neuron itself as the basis for Dth adjustments. Functionally, it makes little difference which mechanism is responsible. Our observations suggest that the change in Dth is quantitatively important. For instance, during AVP, there are only small changes in discharge at a given pressure despite larger changes in diameter, and this clearly results from the offsetting decrease in Dth. In rapid resetting, only minor changes in the vessel wall diameter have been observed, and change in Dth is clearly the predominant mechanism. 18 The present studies suggest that changes in Dth may reflect a very generalized local-control mechanism of arterial baroreceptors and, therefore, of baroreflexes.
